Webinar "MCDA for Policy Making on Orphan Medicinal Products (OMPs)
We continue our series of webinars on MCDA in the field of rare diseases!
On February 26th, at 1:00 PM - 4:30 PM, we will feature our colleagues from Iran.
Why MCDA for orphan drugs?
Orphan technologies often come with high clinical and economic uncertainty: small patient populations, limited evidence base, difficulty in direct comparisons, high cost, and significant ethical/social considerations. MCDA helps to structure the "value" of a technology beyond a single indicator, transparently define criteria and their weighting, and compare alternatives in the face of data shortages. Relaxing standard requirements for orphan drug HTA is not the solution. Orphan drugs require specialized tools capable of determining their value even with limited data.
Included in the program:
-
Why orphan drug policy and decision-making differ from "regular" ones;
-
International models for orphan drug regulation and financing;
-
The role of MCDA in early orphan drug HTA;
-
MCDA in reimbursement and pricing decisions;
-
Integrated decision chain model for orphan drugs;
-
MCDA methodological core: criteria, weights, value assessment, uncertainty management, value matrix.
Webinar Topic:
Multi-Criteria Decision Analysis for Orphan Drug (OD) Policy Development
Speakers:
-
Professor Ali Akbari sari: Full Professor of Health Economics, Director of Iran’s National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.
-
Professor Alireza Olyaeemanesh: Full Professor of Health Policy, Head of Health Economics and Decision Making Department, Iran’s National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.
-
Dr. Mohammadreza Mobinizadeh: Associate Professor of Health Management and Economics, Iran’s National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.
-
Dr. Marita Mohammadshahi: Assistant Professor of Health Economics, Iran’s National Institute for Health Research, Tehran University of Medical Sciences, Tehran, Iran.
Join the international discussion of modern orphan technology assessment tools!
